Advisor Group Holdings, Inc. Cassava Sciences Inc Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 153,020 shares of SAVA stock, worth $449,878. This represents 0.01% of its overall portfolio holdings.

Number of Shares
153,020
Previous 86,410 77.09%
Holding current value
$449,878
Previous $1.07 Million 322.02%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$9.57 - $35.08 $637,457 - $2.34 Million
66,610 Added 77.09%
153,020 $4.5 Million
Q2 2024

Aug 13, 2024
BUY
$12.35 - $26.11 $47,868 - $101,202
3,876 Added 4.7%
86,410 $1.07 Million
Q1 2024

May 10, 2024
SELL
$18.44 - $26.41 $658,492 - $943,101
-35,710 Reduced 30.2%
82,534 $1.67 Million
Q4 2023

Feb 12, 2024
SELL
$12.64 - $30.11 $131,456 - $313,144
-10,400 Reduced 8.08%
118,244 $2.66 Million
Q3 2023

Nov 13, 2023
BUY
$16.64 - $25.32 $324,846 - $494,297
19,522 Added 17.89%
128,644 $2.14 Million
Q2 2023

Aug 10, 2023
SELL
$21.59 - $27.88 $209,207 - $270,157
-9,690 Reduced 8.16%
109,122 $2.68 Million
Q1 2023

May 12, 2023
BUY
$23.46 - $36.44 $554,735 - $861,660
23,646 Added 24.85%
118,812 $2.87 Million
Q4 2022

Feb 10, 2023
BUY
$27.82 - $44.16 $1.58 Million - $2.5 Million
56,659 Added 147.14%
95,166 $2.81 Million
Q3 2022

Nov 14, 2022
SELL
$16.33 - $51.06 $166,190 - $519,637
-10,177 Reduced 20.9%
38,507 $1.61 Million
Q2 2022

Aug 10, 2022
SELL
$17.22 - $38.47 $201,766 - $450,752
-11,717 Reduced 19.4%
48,684 $1.37 Million
Q1 2022

May 04, 2022
BUY
$32.6 - $53.05 $720,883 - $1.17 Million
22,113 Added 57.75%
60,401 $2.26 Million
Q3 2021

Nov 05, 2021
BUY
$41.79 - $135.3 $684,227 - $2.22 Million
16,373 Added 74.71%
38,288 $2.38 Million
Q2 2021

Aug 02, 2021
SELL
$32.15 - $89.72 $1.19 Million - $3.32 Million
-36,974 Reduced 62.79%
21,915 $1.87 Million
Q1 2021

May 13, 2021
BUY
$7.09 - $87.95 $316,320 - $3.92 Million
44,615 Added 312.56%
58,889 $2.65 Million
Q4 2020

Feb 10, 2021
SELL
$6.79 - $12.25 $38,268 - $69,041
-5,636 Reduced 28.31%
14,274 $97,000
Q3 2020

Nov 12, 2020
BUY
$2.86 - $11.51 $43,349 - $174,457
15,157 Added 318.89%
19,910 $229,000
Q2 2020

Aug 14, 2020
BUY
$2.04 - $9.64 $4,955 - $23,415
2,429 Added 104.52%
4,753 $14,000
Q1 2020

May 18, 2020
BUY
$3.26 - $9.65 $7,576 - $22,426
2,324 New
2,324 $9,000

Others Institutions Holding SAVA

# of Institutions
206
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $118M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email